Mostrando 3 resultados de: 3
Filtros aplicados
Área temáticas
Enfermedades(2)
Medicina forense; incidencia de enfermedades(2)
Medicina y salud(2)
Farmacología y terapéutica(1)
Otros problemas y servicios sociales(1)
Año de Publicación
2022(3)
Author Correction: Spatial and temporal fluctuations in COVID-19 fatality rates in Brazilian hospitals (Nature Medicine, (2022), 28, 7, (1476-1485), 10.1038/s41591-022-01807-1)
OtherAbstract: In the version of this article initially published, there was an error in the spelling of Raphael SoPalabras claves:Autores:Aguiar R.S., Araujo L.J.T., Bastos L.S., Bernardo M. Gutierrez, Bhatt S., Blenkinsop A., Bonfim D.M., Brizzi A., Buss L.F., Castro M.C., Costa S.F., Croda J., da Silva Candido D., de Souza W.M., de Souza-Santos A.A., Dye C., Faria N.R., Flaxman S., Fonseca P.L.C., Geddes V.E.V., Hawryluk I., Lemey P., Levin A.S., Mellan T., Miscouridou X., Mishra S., Monod M., Moreira F.R.R., Nelson B.W., Pereira R.H.M., Prete C.A., Ranzani O.T., Ratmann O., Sabino E.C., Schnekenberg R.P., Semenova E., Servo L.M.S., Sonabend R., Souza R.P., Whittaker C., Xi X.Fuentes:scopusEffectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study
ArticleAbstract: Background: COVID-19 vaccines have proven highly effective among individuals without a previous SARSPalabras claves:Autores:Andrews J.R., Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., Croda J., Cummings D.A.T., de Araujo Oliveira V., Dean N.E., Dorion M., Hitchings M.D.T., Júnior J.B.S., Ko A.I., Lind M.L., Machado T.M., Mauricio L. Barreto, Paixão E.S., Pearce N., Penna G.O., Ranzani O.T., Werneck G.L.Fuentes:scopusUnderstanding the Potential Impact of Different Drug Properties on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission and Disease Burden: A Modelling Analysis
ArticleAbstract: Background. The public health impact of the coronavirus disease 2019 (COVID-19) pandemic has motivatPalabras claves:covid-19, epidemiology, modelling, SARS-COV-2, therapeuticsAutores:Alvarez-Moreno C.A., Angkasekwinai N., Boonyasiri A., Chanda D., Charoenpong L., Chayakulkeeree M., Cooke G.S., Costa S.F., Croda J., Cucunubá Z.M., Djaafara B.A., Esteban Ortiz-Prado, Estofolete C.F., Faria N.R., Forero-Peña D.A., Ghani A.C., Gibb D.M., Gordon A.C., Grillet M.E., Hallett T.B., Hamers R.L., Hamlet A., Irawany V., Jitmuang A., Keurueangkul N., Kimani T.N., Lampo M., Levin A.S., Lopardo G., Mustafa R., Nayagam S., Ngamprasertchai T., Njeri N.I.H., Nogueira M.L., Perroud M.W., Phillips A.N., Promsin P., Qavi A., Rodger A.J., Sabino E.C., Sangkaew S., Sari D., Sirijatuphat R., Sposito A.C., Srisangthong P., Thompson H.A., Triana L.C., Udwadia Z.F., Valderrama-Beltrán S.L., Walker P.G.T., Watson O.J., Whittaker C., Winskill P.Fuentes:googlescopus